Sign in

You're signed outSign in or to get full access.

Michel Atwood

Chief Financial Officer at INTERPARFUMSINTERPARFUMS
Executive
Board

About Michel Atwood

Michel Atwood, age 55, is Interparfums, Inc.’s Chief Financial Officer (since Sept. 6, 2022) and a director first elected at the September 2022 annual meeting; he previously served in senior finance and M&A roles at Estée Lauder and spent over two decades at Procter & Gamble culminating as Divisional CFO of Global Prestige Fragrances . He holds a master’s in software engineering (INSA Lyon), a master’s in international finance (HEC Paris), and is a Certified Management Accountant; he has lived and worked across France, Switzerland, the U.S., Canada, Turkey and Italy . Under his tenure window, company TSR stood at 197.35 at 12/31/24 (base=100 at 12/31/19) and net income rose from $151M (2022) to $203M (2024); the 5‑year TSR also outperformed the company’s peer group in the corporate performance graph (197.35 vs. 101.55 at 12/31/24) . He serves as both an executive officer and board member (not independent), while core board committees (Audit, Compensation, Nominating) are comprised solely of independent directors .

Past Roles

OrganizationRoleYearsStrategic Impact
Estée LauderStrategic oversight for fragrance category; senior M&A (integration, divestitures); operational accountability for several fragrance brands2018–Mar 2022Drove cross-brand R&D and supply-chain synergies; oversaw fragrance portfolio initiatives and transactions
Independent (M&A advisor/private investor)Consultant2017–2018Advised on fragrance license acquisitions and investments
Procter & GambleDivisional CFO, Global Prestige Fragrances; earlier CFO Global Markets – Prestige; Director of Strategic Planning, Licensing & Acquisition1995–2017Led global finance teams (90 and 60 staff), shaped prestige fragrance strategy, and spearheaded the Prestige divestiture to Coty

External Roles

  • No current public company directorships or external committee roles disclosed for Mr. Atwood in the proxy; section lists only his IPAR directorship and management role .

Fixed Compensation

Metric202220232024
Base Salary ($)161,218 525,000 700,000
Annual Bonus ($)150,000 125,000 125,000
NotesJoined 9/6/22; salary prorated from $500k CFO has a verbal arrangement: $100k guaranteed bonus + $100k milestone bonus opportunity; 2024 discretionary bonus paid was $125k

The Compensation Committee emphasizes higher fixed cash for U.S. executives (relative to European operations), with bonuses discretionary and without preset targets to maintain flexibility .

Performance Compensation

Stock Options (CFO-specific awards)

Grant DateTypeSharesStrike ($/sh)TermVestingGrant-date FV ($)
12/30/2022NQO5,00097.846 yrs20% annually starting 1 year post-grant101,814
12/29/2023NQO4,000147.716 yrs20% annually starting 1 year post-grant140,327
12/31/2024NQO4,000130.606 yrs20% annually starting 1 year post-grant133,251
  • Plan mechanics: options granted at fair market value, 6‑year term, vest 20% per year after the first anniversary; options generally forfeit at termination (death/disability exceptions per plan) .
  • 2024 plan-based disclosure notes the 12/31/24 grant of 4,000 options at $130.60; closing price $131.51 that day .
  • No PSUs/RSUs for U.S. executives; IPAR historically has not granted restricted stock to executive officers .

Annual Incentive Structure (U.S.)

ComponentDesign2024 Outcome
Guaranteed bonus$100k per verbal agreementPaid via discretionary $125k bonus in 2024 (same as 2023)
Milestone bonus$100k opportunity (criteria not disclosed)Not separately disclosed as paid; only discretionary $125k shown
Performance metricsPrimarily discretionary (no preset targets) for U.S.; European operations also discretionary but historically higher bonus mixCompensation Committee expressly did not tie CAP (pay-versus-performance) to specific financial metrics for 2024

Equity Ownership & Alignment

ItemDetail
Beneficial ownership (as of July 1, 2025 record set)2,800 shares (all underlying options exercisable within 60 days); <1% of shares outstanding
Options outstanding (12/31/24)2,000 exercisable / 3,000 unexercisable at $97.84 exp. 12/30/28; 800 exercisable / 3,200 unexercisable at $147.71 exp. 12/28/29; 0 exercisable / 4,000 unexercisable at $130.60 exp. 12/30/30
Option exercises in 2024None by Atwood (CEO and others exercised; CFO did not)
Ownership guidelinesNone for executives (no minimum required)
Hedging/pledgingAnti‑hedging policy prohibits hedging/monetization; policy requires pre‑clearance and trading windows; no pledging policy disclosed
Section 16 complianceCompany reports no late filings for insiders based on Forms 3/4/5 review

Vesting cadence implies potential incremental sellable supply of ~1,000 options from the 2022 grant vesting annually (2023–2027) and ~800 options from each of the 2023 and 2024 grants (2024/2025–2028/2029), subject to trading windows and personal decisions .

Employment Terms

  • Employment agreement: None disclosed for Mr. Atwood (U.S. executives do not have employment agreements; flexibility in base salary cited) .
  • Severance/Change‑of‑Control: No severance multiples, CoC triggers, or accelerated vesting terms disclosed for Mr. Atwood; clawback policy (SEC/Nasdaq compliant) applies to incentive-based compensation received on/after Oct. 2, 2023 .
  • Non‑compete/non‑solicit/garden leave/post‑termination consulting: Not disclosed for Mr. Atwood (agreements described in detail only for Messrs. Madar and Benacin) .
  • Retirement/benefits: U.S. 401(k) with match; no nonqualified deferred comp; no pension benefits for Atwood; no perquisites shown for 2024 .

Board Governance (Director Service, Committees, Independence)

  • Board service: Director since Sept. 2022; CFO and director (management director; not independent) .
  • Board committees: Audit, Executive Compensation & Stock Option, and Nominating Committees composed entirely of independent directors; chairs: François Heilbronn (all three) .
  • Attendance: Board held 23 meetings (incl. committee) in 2024; all directors attended at least 75% of meetings/consents of the full board and relevant committees .
  • Leadership/independence context: CEO is also Chairman; Board has no Lead Independent Director; board notes comfort with dual leadership given large owner-operators (Madar/Benacin) and segment oversight split; Atwood’s dual role (CFO + director) is standard for management directors but reduces board independence composition at the margin .

Director Compensation (Context)

  • Director fees/equity apply to non‑employee directors only (meeting fees and annual option grants of 1,500 shares in 2024); employee directors (e.g., CFO) are compensated through executive pay, not director retainers .

Compensation Structure Analysis

  • Cash vs. equity mix: U.S. CFO pay is salary‑heavy with modest discretionary cash bonus; equity awards are annual stock options (no RSUs/PSUs) with fair values of ~$102k (2022), ~$140k (2023), ~$133k (2024) .
  • Performance linkage: Company explicitly did not use financial performance measures to link “Compensation Actually Paid” to company performance for 2024; U.S. bonuses are discretionary without preset targets, indicating limited formulaic pay‑for‑performance rigor for CFO cash pay .
  • Repricing/modification: No option repricings disclosed; options issued at fair market value with 6‑year terms and standard vesting .
  • Clawback/hedging controls: SEC/Nasdaq‑compliant clawback policy in effect; robust anti‑hedging policy and strict trading windows/pre‑clearance .
  • Ownership alignment: No executive ownership guidelines (uncommon among mid/large‑cap peers), but Atwood’s equity exposure comes via multi‑year option grants; no pledging disclosure .

Key Multi‑Year Data

CFO – Summary Compensation

Metric202220232024
Salary ($)161,218 525,000 700,000
Bonus ($)150,000 125,000 125,000
Option Awards (Grant‑date FV, $)101,814 140,327 133,251
Total ($)413,032 790,327 958,251

Equity – Outstanding Options (12/31/24)

Option TrancheExercisableUnexercisableStrike ($)Expiration
12/30/2022 grant2,000 3,000 97.84 12/30/2028
12/29/2023 grant800 3,200 147.71 12/28/2029
12/31/2024 grant0 4,000 130.60 12/30/2030

Pay vs Performance (Company-level context)

YearTSR ($, $100 base at 12/31/19)Peer Group TSR ($)Net Income ($M)
202083.75 118.87 50
2021149.91 145.11 110
2022138.82 116.33 151
2023210.93 114.95 188
2024197.35 101.55 203

The company also reports a custom peer set for pay‑versus‑performance (PVP) disclosure and notes that 2024 compensation actually paid was not tied to a company‑selected financial measure; the PVP table shows TSR of 197.35 and custom peer TSR of 147.04 for 2024 .

Compensation Committee & Peer Group

  • Committee composition: Independent directors François Heilbronn (Chair), Robert Bensoussan, and Veronique Gabai‑Pinsky; broad reliance on experience rather than formal benchmarking or outside consultants for executive pay .
  • Peer group for performance graph updated in 2023 to reflect current competitive landscape (e.g., ELC, P&G, e.l.f. Beauty, Coty, L’Oréal, LVMH, Natura, Olaplex, Shiseido) .
  • Say‑on‑pay: 2024 shareholder advisory vote “overwhelmingly approved” compensation policies and decisions .

Risk Indicators & Red Flags

  • Governance structure: CEO also Chairman; no Lead Independent Director; management directors include the CFO; core committees remain fully independent .
  • Ownership policy: No executive stock ownership guidelines (potential alignment gap); anti‑hedging in place; pledging policy not disclosed .
  • Related‑party transactions: Intercompany loans between subsidiaries and the parent to fund dividends/repurchases in 2023–2024; approved and disclosed, but notable from a governance optics standpoint .
  • Clawback: SEC/Nasdaq‑compliant clawback policy adopted (covers three prior fiscal years for incentive‑based compensation after restatement trigger) .
  • Section 16 compliance: No late filings reported for 2024 .
  • Option repricing: None disclosed .

Say‑on‑Pay & Shareholder Feedback

  • The Compensation Committee cited the “overwhelming” approval of the 2024 say‑on‑pay vote and maintained current policies (discretionary bonuses, options for long‑term) .

Expertise & Qualifications

  • Degrees: Master’s in software engineering (INSA Lyon) and master’s in international finance (HEC Paris); CMA designation .
  • Domain expertise: Finance leadership (Divisional CFO), fragrance industry strategy and M&A (P&G, Estée Lauder), global operating experience .

Work History & Career Trajectory

  • 2022–Present: CFO, Interparfums, Inc.; director since Sept. 2022 .
  • 2018–2022: Estée Lauder – fragrance category strategy and brand operations; senior M&A integration and divestitures .
  • 2017–2018: Independent M&A advisor/private investor .
  • 1995–2017: P&G – Divisional CFO Global Prestige Fragrances; prior roles in strategy, licensing, acquisitions; CFO Global Markets – Prestige .

Investment Implications

  • Alignment and retention: Atwood’s pay mix is salary‑heavy with modest annual options; absence of stock ownership guidelines and discretionary bonus design limit explicit pay‑for‑performance alignment, though multi‑year options provide leverage to share price; no disclosed severance/CoC protections could be a retention risk vs large‑cap peers offering formal arrangements .
  • Trading/overhang signals: Option vesting cadence (1,000 from 2022 grant annually; ~800 from 2023/2024 grants annually on their schedules) creates periodic potential liquidity events but pre‑clearance and blackout windows constrain timing; no 2024 option exercises by Atwood .
  • Governance considerations: Dual roles (CFO + director) and combined CEO/Chair with no Lead Independent Director warrant monitoring; committees remain fully independent; say‑on‑pay support was strong .
  • Performance backdrop: 5‑year TSR and net income trajectory are favorable; company states CAP not tied to financial metrics in 2024 (reduces direct pay‑performance sensitivity), but long‑term options maintain upside linkage to equity performance .